There are more types of sickle cell crisis than a vaso-occlusive crisis, writes columnist Mary Shaniqua, who summarizes ...

The Pediatric Emergency Medicine and Pediatric Hematology/Oncology divisions at MUSC have joined forces to create and test an ...

The Pediatric Emergency Medicine and Pediatric Hematology/Oncology divisions at the Medical University of South Carolina ...

For the first time in his life, a young New Jersey man is pain-free thanks to a new gene treatment working to cure patients ...

Individuals with both sickle cell disease (SCD) and sickle cell trait are at higher risk than others of developing renal medullary cancer (RMC), the rarest and deadliest subtype of kidney cancer.

For people living with sickle cell disease, joint pain, especially in the knees, can be a frustrating and persistent companion.When swelling and fluid build-up occur in the joint, doctors often ...

Vertex Pharma's £1.65 million ($2.05 million) gene-editing therapy for sickle cell disease (SCD), Casgevy, has been given the green light for use by the NHS in England under a managed access ...

Pfizer is voluntarily withdrawing its sickle cell disease (SCD) therapy Oxbryta from all world markets after finding an "imbalance" in deaths in its clinical trials programme. It's a blow to the ...

By Linda Naa Deide Aryeetey Accra, May 28.GNA- Ghana and the global medical community are mourning the passing of Professor Felix Israel Domeno Konotey-Ahulu, a renowned Ghanian physician and ...

Adolescents and young adults with sickle cell disease may face challenges in accessing physical therapy, a study reports.

In a first-in-human phase 1/2 study in seven patients with sickle cell disease, autologous hematopoietic stem cell lentiviral gene therapy using reduced-intensity conditioning was considered ...

The advance promises to improve diabetes research and cell-based ... Researchers Identify a Dual Origin of Cells Controlling Puberty and Reproduction May 21, 2025 — Researchers have shown that ...